Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119. Published online 2022 May 20 DOI: https://doi.org/10.3857/roj.2021.01060
Citations to this article as recorded by 
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer
Ruth Anne Laura Willems, Charlotte Biesmans, Elena Campello, Paolo Simioni, Bas de Laat, Judith de Vos-Geelen, Mark Roest, Hugo ten Cate
Seminars in Thrombosis and Hemostasis.2024; 50(03): 429. CrossRef
Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy
Qihang Wu, Han Mao, Zhengting Jiang, Dong Tang
Immunology.2024;[Epub] CrossRef
Progress in the development of vaccines for pancreatic adenocarcinoma
Singer Mahmoud, Elsayed Ahmed M, Husseiny Mohamed I
Annals of Pancreatic Disorders and Treatment.2024; 6(1): 001. CrossRef
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Cancers.2023; 15(3): 768. CrossRef
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, Philippe Martinive, Dirk Van Gestel, Mohammad Krayem
Frontiers in Immunology.2023;[Epub] CrossRef
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, Silvia C. Formenti
Nature Reviews Clinical Oncology.2023; 20(8): 543. CrossRef
Stereotactic body radiation therapy for pancreatic cancer: a potential ally in the era of immunotherapy?
Jin-hong Park
Radiation Oncology Journal.2022; 40(3): 169. CrossRef